|
Beurs gesloten -
NYSE
22:00:00 20-11-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 2,900 USD | -5,23% |
|
-4,92% | +61,11% |
| 10/11 | Protalix BioTherapeutics, Inc. bevestigt winstverwachting voor heel 2026 opnieuw | CI |
| 10/11 | Protalix BioTherapeutics, Inc., Q3 2026 Earnings Call, Nov 10, 2026 |
ETF's gepositioneerd op Protalix BioTherapeutics, Inc.
| Naam | Var. 1 jan | Gewicht | Volume | |
|---|---|---|---|---|
| +0,11% | 0,03% | 1 518 M€ | ||
| +8,53% | 0,02% | 53 M€ | ||
| -0,82% | 0,01% | 1 568 M€ | ||
| +11,98% | 0,01% | 3 050 M€ | ||
| -0,80% | 0,01% | 15 028 M€ | ||
| +7,07% | 0,01% | 18 M€ | ||
| +2,46% | 0,01% | 520 M€ | ||
| +9,81% | 0,01% | 14 676 M€ | ||
| -1,25% | 0% | 9 M€ | ||
| +4,16% | 0% | 1 540 M€ | ||
| +4,25% | 0% | 82 179 M€ | ||
| -5,03% | 0% | 1 395 M€ | ||
| +1,51% | 0% | 4 863 M€ | ||
| -1,23% | 0% | 19 M€ | ||
| +1,67% | 0% | 60 M€ | ||
| +1,69% | 0% | 29 M€ | ||
| +1,84% | 0% | 41 M€ | ||
| -12,58% | 0% | 162 M€ | ||
| +2,07% | 0% | 88 M€ | ||
| 0,00% | 0% | 43 M€ | ||
| +1,71% | 0% | 91 M€ | ||
| +1,61% | 0% | 16 M€ | ||
| +1,59% | 0% | 110 M€ | ||
| +1,25% | 0% | 113 M€ | ||
| +3,98% | 0% | 7 M€ | ||
| +2,52% | 0% | 43 M€ | ||
| +2,16% | 0% | 194 M€ | ||
| +2,62% | 0% | 62 M€ | ||
| -0,62% | 0% | 513 M€ | ||
| -12,73% | 0% | 20 M€ | ||
| -27,11% | -.--% | 538 M€ |
Werknemers
226
Sector
Farmaceutische producten
Kies jouw editie
Alle financiële informatie op nationaal niveau
















